hackint0sh/temp-data huggingface dataset:
protocolSection identificationModule nctId: NCT06267625, orgStudyIdInfo id: Elderly Individuals, briefTitle: Physical Impairments in Elderly Individuals, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-03-15, primaryCompletionDateStruct date: 2026-03-15, completionDateStruct date: 2026-12-15, studyFirstPostDateStruct date: 2024-02-20, lastUpdatePostDateStruct date: 2024-02-20, sponsorCollaboratorsModule leadSponsor name: Izmir Democracy University, class: OTHER, descriptionModule briefSummary: There are no studies in the literature reporting the dyspnea, posture, strength, physical activity, functional mobility and balance in elderly individuals. The aims of this observational study are; 1) to evaluate dyspnea, posture, strength, physical activity, functional mobility and balance in elderly individuals, 2) to reveal the relationships between these parameters of research group., conditionsModule conditions: Aging Disorder, designModule studyType: OBSERVATIONAL, designInfo observationalModel: CASE_CONTROL, timePerspective: CROSS_SECTIONAL, enrollmentInfo count: 50, type: ESTIMATED, armsInterventionsModule interventions name: Physical Evaluations of individuals, outcomesModule primaryOutcomes measure: Dyspnea score, secondaryOutcomes measure: Posture score, secondaryOutcomes measure: Cough strength, secondaryOutcomes measure: Handgrip strength, secondaryOutcomes measure: Functional mobility score, secondaryOutcomes measure: Physical activity score, secondaryOutcomes measure: Functional Mobility score, secondaryOutcomes measure: Balance score, secondaryOutcomes measure: Cognitive function score, eligibilityModule sex: ALL, minimumAge: 65 Years, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Izmir Democracy University, city: İzmir, zip: 35140, country: Turkey, contacts name: GÜLŞAH BARĞI, Assoc.Dr., role: CONTACT, phone: +90 531 793 8766, email: gulsahbargi35@gmail.com, contacts name: ESRA SUDE AKIN, BSc, role: CONTACT, phone: +90 543 581 4690, email: esrasudeakin@gmail.com, geoPoint lat: 38.41273, lon: 27.13838, hasResults: False
protocolSection identificationModule nctId: NCT06267612, orgStudyIdInfo id: KY20231109-11, briefTitle: Corheart 6 LVAS Long-term Follow-up Study, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-02-10, primaryCompletionDateStruct date: 2030-06-30, completionDateStruct date: 2030-06-30, studyFirstPostDateStruct date: 2024-02-20, lastUpdatePostDateStruct date: 2024-02-20, sponsorCollaboratorsModule leadSponsor name: Nanjing First Hospital, Nanjing Medical University, class: OTHER, descriptionModule briefSummary: The purpose of this clinical study is to explore the long-term efficacy and safety of the Corheart 6 Left Ventricular Assist System (LVAS) as a treatment for patients with advanced heart failure.The study will be a single-arm, prospective, single-center, non-blinded, and non-randomized study with a follow-up duration of five years., conditionsModule conditions: Heart Failure, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NA, interventionModel: SINGLE_GROUP, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 30, type: ESTIMATED, armsInterventionsModule interventions name: Corheart 6 Left Ventricular Assist System, outcomesModule primaryOutcomes measure: Device implantaion success rate at 24 months post-implantation, secondaryOutcomes measure: Quality of Life as measured by the Kansas City Cardiomyopathy Questionnaire-23 (KCCQ-23), secondaryOutcomes measure: Quality of Life as measured by the EuroQoL-5D-5L (EQ-5D-5L) questionnaire, secondaryOutcomes measure: Functional status as measured by the Six Minute Walk Test (6MWT), secondaryOutcomes measure: Functional status as measured by the New York Heart Association (NYHA) Classification, secondaryOutcomes measure: Stroke severity as assessed with the National Institutes of Health Stroke Scale (NIHSS) score, secondaryOutcomes measure: Stroke severity as assessed by the modified Rankin Scale (mRS) score, secondaryOutcomes measure: Adverse events, secondaryOutcomes measure: Device-related re-operations, secondaryOutcomes measure: Device-related re-hospitalizations, secondaryOutcomes measure: Overall survival, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Nanjing First Hospital, city: Nanjing, state: Jiangsu, country: China, contacts name: Zhibing Qiu, role: CONTACT, email: qiuzhibing2009@163.com, geoPoint lat: 32.06167, lon: 118.77778, hasResults: False
protocolSection identificationModule nctId: NCT06267599, orgStudyIdInfo id: ACAR-Style Bladder Suture, briefTitle: Bladder Suture in Uterus-Sparing Surgery and Hysterectomy for Placenta Percreta, statusModule overallStatus: COMPLETED, startDateStruct date: 2023-09-01, primaryCompletionDateStruct date: 2023-12-01, completionDateStruct date: 2024-01-01, studyFirstPostDateStruct date: 2024-02-20, lastUpdatePostDateStruct date: 2024-02-20, sponsorCollaboratorsModule leadSponsor name: Necmettin Erbakan University, class: OTHER, descriptionModule briefSummary: This study aimed to evaluate the short-term and long-term complications of placenta percreta with bladder invasion. This evaluation focuses on cases where bladder dissection and ACAR-style bladder sutures were applied in cases of placenta percreta with bladder invasion that underwent uterine-sparing surgery or hysterectomy., conditionsModule conditions: Placenta Percreta, conditions: Bladder Injury, conditions: Sutures, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: RETROSPECTIVE, enrollmentInfo count: 81, type: ACTUAL, armsInterventionsModule interventions name: ACAR-Style Bladder Suture, outcomesModule primaryOutcomes measure: Comparison of intraoperative bleeding and complication rates of the two groups, primaryOutcomes measure: Comparison of postoperative bleeding between two groups, primaryOutcomes measure: Comparison of complication rate between two groups, eligibilityModule sex: FEMALE, minimumAge: 18 Years, maximumAge: 50 Years, stdAges: ADULT, contactsLocationsModule locations facility: Cemre Alan, city: Konya, country: Turkey, geoPoint lat: 37.87135, lon: 32.48464, hasResults: False
protocolSection identificationModule nctId: NCT06267573, orgStudyIdInfo id: Kerolos protocol, briefTitle: Thoracoabdominal Aortic Aneurysms, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-09, primaryCompletionDateStruct date: 2025-09-15, completionDateStruct date: 2026-09-10, studyFirstPostDateStruct date: 2024-02-20, lastUpdatePostDateStruct date: 2024-02-20, sponsorCollaboratorsModule leadSponsor name: Assiut University, class: OTHER, descriptionModule briefSummary: Evaluation of the effectiveness of the different modalities for treatment of thoracoabdominal aortic aneurysms. FEVAR and BEVAR devices are widely used now due to its feasability and wide range of use . We aim to evaluate the effectiveness of these new devices in the management of TAAA, conditionsModule conditions: Thoracoabdominal Aortic Aneurysm, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: PROSPECTIVE, enrollmentInfo count: 100, type: ESTIMATED, armsInterventionsModule interventions name: Fenestrated and branched endovascular devices for TAAA, outcomesModule primaryOutcomes measure: Successful cannulation of the target vessels with complete in-line flow to target organs., eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, hasResults: False
protocolSection identificationModule nctId: NCT06267560, orgStudyIdInfo id: CTQJ230A12303, briefTitle: Lp(a) Lowering Study of Pelacarsen (TQJ230) in US Black/African American and Hispanic Participants With Elevated Lp(a) and Established ASCVD, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-05-27, primaryCompletionDateStruct date: 2027-06-21, completionDateStruct date: 2027-06-21, studyFirstPostDateStruct date: 2024-02-20, lastUpdatePostDateStruct date: 2024-02-20, sponsorCollaboratorsModule leadSponsor name: Novartis Pharmaceuticals, class: INDUSTRY, descriptionModule briefSummary: Study CTQJ230A12303 is a randomized, double-blind placebo-controlled, Phase IIIb study to evaluate the efficacy, safety and tolerability of pelacarsen (TQJ230) 80 mg s.c. QM compared with placebo s.c. QM in US Black/African American and Hispanic participants with established ASCVD and elevated levels of Lp(a) who are treated for cardiovascular (CV) risk factors according to local practice/guidelines for the reduction of cardiovascular risk., conditionsModule conditions: Elevated Lp(a) and Established Atherosclerotic Cardiovascular Disease, designModule studyType: INTERVENTIONAL, phases: PHASE3, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: QUADRUPLE, maskingDescription: Eligible participants will be randomized after the screening period or Guideline recommended SOC implementation period (if needed) in a 2:1 ratio to subcutaneous injections of pelacarsen (TQJ230) 80 mg QM or placebo QM either to be self-administered or administered by caregiver or site personnel approximately every 30 days for up to 12 months., whoMasked: PARTICIPANT, whoMasked: CARE_PROVIDER, whoMasked: INVESTIGATOR, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 400, type: ESTIMATED, armsInterventionsModule interventions name: TQJ230, interventions name: Placebo, outcomesModule primaryOutcomes measure: Change in log-transformed Lp(a) concentration from baseline at week 52, secondaryOutcomes measure: Incidence proportion of study discontinuations due to TEAEs, secondaryOutcomes measure: Incidence proportion of Treatment emergent adverse events (TEAEs) of special interest, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 80 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06267547, orgStudyIdInfo id: 2023P003522, briefTitle: Healthy Activities Improve Lives (HAIL), acronym: HAIL, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-04-23, primaryCompletionDateStruct date: 2026-12-01, completionDateStruct date: 2027-02-01, studyFirstPostDateStruct date: 2024-02-20, lastUpdatePostDateStruct date: 2024-04-29, sponsorCollaboratorsModule leadSponsor name: Massachusetts General Hospital, class: OTHER, collaborators name: National Institute on Aging (NIA), descriptionModule briefSummary: The investigators have developed an online platform to support the 8-week, F\&S! exercise program called the Healthy Activity Improves Lives (HAIL) online platform. The aim of this study is to perform a cluster randomization of four racially diverse churches or senior centers to either the standard F\&S! program, or the combined HAIL Online Platform + F\&S! program to examine the efficacy of the HAIL online platform + F\&S! program for older adults in black communities., conditionsModule conditions: Physical Activity, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 120, type: ESTIMATED, armsInterventionsModule interventions name: HAIL Online Platform, interventions name: Fit and Strong! Program, outcomesModule primaryOutcomes measure: Feasibility and Retention, primaryOutcomes measure: Acceptability, primaryOutcomes measure: Acceptability (Feedback Form), primaryOutcomes measure: Acceptability (Exit Interviews), secondaryOutcomes measure: Changes in Physical Activity (Steps), secondaryOutcomes measure: Changes in Physical Activity (MVPA), secondaryOutcomes measure: Changes in Aerobic Capacity, secondaryOutcomes measure: Changes in Physical Strength, secondaryOutcomes measure: Motivation to Change, secondaryOutcomes measure: Utilization of Healthcare Resources, secondaryOutcomes measure: Fall History, secondaryOutcomes measure: Chronic Conditions, secondaryOutcomes measure: Changes in Overall Wellbeing, secondaryOutcomes measure: Changes in Depression, secondaryOutcomes measure: Changes in Anxiety, secondaryOutcomes measure: Changes in Physical Functioning, secondaryOutcomes measure: Changes in Social Isolation, secondaryOutcomes measure: Changes in Confidence in Exercises, otherOutcomes measure: Satisfaction with program, otherOutcomes measure: Satisfaction with program, otherOutcomes measure: Use of online program, otherOutcomes measure: Use of online program, eligibilityModule sex: ALL, minimumAge: 60 Years, maximumAge: 100 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Roslindale Baptist Church, status: RECRUITING, city: Boston, state: Massachusetts, zip: 02131, country: United States, contacts name: Lydia Townsend, role: CONTACT, geoPoint lat: 42.35843, lon: -71.05977, hasResults: False
protocolSection identificationModule nctId: NCT06267534, orgStudyIdInfo id: YCH, briefTitle: Mindfulness-based Mobile Applications Program, statusModule overallStatus: COMPLETED, startDateStruct date: 2022-09-09, primaryCompletionDateStruct date: 2022-09-22, completionDateStruct date: 2022-09-22, studyFirstPostDateStruct date: 2024-02-20, lastUpdatePostDateStruct date: 2024-02-20, sponsorCollaboratorsModule leadSponsor name: Yu-Chien Huang, class: OTHER, descriptionModule briefSummary: The goal of this type of study: quasi-experimental clinical trial . The purpose of this study is to explore the effects of applying mindfulness-based mobile applications program to maintaining mental health of emergency nurses during providing care to COVID-19 patients. The main question\[s\] it aims to answer are:1. To explore the effect of mindfulness-based mobile device-assisted program on care stress of emergency nurses caring for COVID-19 patients.2. To explore the impact of mindfulness-based mobile device-assisted programs on the psychological distress of emergency nurses caring for COVID-19 patients.3. To explore the impact of a mindfulness-based mobile device-assisted program on compassion fatigue in emergency nurses caring for COVID-19 patients.Participants will Mindfulness-based mobile device is provided to experimental group as assistance for 2 weeks. In the contrary, no intervention measure was assigned in the control group. Scale exam was performed before and after the program in both groups at the same time., conditionsModule conditions: COVID-19, conditions: Cell Phone Use, conditions: Nurse, conditions: Mental Health, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: SEQUENTIAL, primaryPurpose: SUPPORTIVE_CARE, maskingInfo masking: SINGLE, whoMasked: PARTICIPANT, enrollmentInfo count: 102, type: ACTUAL, armsInterventionsModule interventions name: mindfulness-based mobile applications program, outcomesModule primaryOutcomes measure: The impact of mindfulness-based mobile device assistance program on the care stress of emergency nursing staff caring for COVID-19 patients, primaryOutcomes measure: Effects of mindfulness-based mobile device assistance program on psychological distress among emergency nursing staff caring for COVID-19 patients, primaryOutcomes measure: Effects of a mindfulness-based mobile device-assisted program on compassion fatigue among emergency nursing staff caring for COVID-19 patients, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Yu-Chien Huang, city: Taipei, state: Zhongzheng District, zip: 100, country: Taiwan, geoPoint lat: 25.04776, lon: 121.53185, hasResults: False
protocolSection identificationModule nctId: NCT06267495, orgStudyIdInfo id: EOCXLFE, briefTitle: Epithelium-on Cross-linking Versus Observation of Fellow Eyes of Patients With Unilateral Clinically Evident Keratoconus, statusModule overallStatus: COMPLETED, startDateStruct date: 2017-01-01, primaryCompletionDateStruct date: 2024-01-31, completionDateStruct date: 2024-01-31, studyFirstPostDateStruct date: 2024-02-20, lastUpdatePostDateStruct date: 2024-02-20, sponsorCollaboratorsModule leadSponsor name: Assiut University, class: OTHER, descriptionModule briefSummary: Keratoconus (KC) is a bilateral asymmetric progressive corneal degenerative disease. The management of young patients, diagnosed with clinically evident KC in one eye and with no clinical signs of KC in the other eye, represents a real challenge for many ophthalmologists.The aim of the current study is to investigate the effectiveness and safety of epithelium-on accelerated CXL to stabilize the eye with no clinical signs of KC, in young patients with unilateral clinically evident KC, compared with standard care and follow-up only., conditionsModule conditions: Keratoconus, designModule studyType: OBSERVATIONAL, designInfo observationalModel: OTHER, timePerspective: RETROSPECTIVE, enrollmentInfo count: 40, type: ACTUAL, armsInterventionsModule interventions name: Epithelium-on corneal cross-linking (epi-on CXL), outcomesModule primaryOutcomes measure: Steep keratometry value, primaryOutcomes measure: Maximum keratometry value, secondaryOutcomes measure: Corrected distance visual acuity, eligibilityModule sex: ALL, minimumAge: 12 Years, maximumAge: 30 Years, stdAges: CHILD, stdAges: ADULT, contactsLocationsModule locations facility: Tiba Eye Center, city: Assiut, zip: 71516, country: Egypt, geoPoint lat: 27.18096, lon: 31.18368, hasResults: False
protocolSection identificationModule nctId: NCT06267482, orgStudyIdInfo id: 122311, briefTitle: Using ROSA for Challenging The TKA Standard of Care, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-04-16, primaryCompletionDateStruct date: 2025-04, completionDateStruct date: 2025-06, studyFirstPostDateStruct date: 2024-02-20, lastUpdatePostDateStruct date: 2024-04-18, sponsorCollaboratorsModule leadSponsor name: Lawson Health Research Institute, class: OTHER, collaborators name: Zimmer Biomet, descriptionModule briefSummary: This is a prospective, randomized controlled trial using the cruciate retaining, MC Persona to comparing the conventional TKA to ROSA assisted TKA. Patients will be randomized to one of three study trial arms.1. Standard of care medial parapetallar approach (Control)2. ROSA PSA medial parapetallar approach3. ROSA PSA medial subvastus approach Participants will be followed for 1 year post surgery with a combination of perioperative parameters, imaging, patient reported outcomes, functional outcomes, blood and tissue sampling for inflammatory information and activity levels., conditionsModule conditions: Knee Osteoarthritis, designModule studyType: INTERVENTIONAL, phases: PHASE4, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: HEALTH_SERVICES_RESEARCH, maskingInfo masking: NONE, enrollmentInfo count: 90, type: ESTIMATED, armsInterventionsModule interventions name: ROSA PSA Parapatellar Approach, interventions name: ROSA PSA Subvastus Approach, outcomesModule primaryOutcomes measure: Functional Outcome - Weight-bearing CT scan, primaryOutcomes measure: Functional Outcome - 3D Ultrasound, primaryOutcomes measure: Functional Outcome - Timed Up and Go test, primaryOutcomes measure: Patient health status - Knee Society Score, primaryOutcomes measure: Patient health status - EuroQuol Survey, primaryOutcomes measure: Patient health status - Knee Injury and Osteoarthritis Outcome Score, primaryOutcomes measure: Patient health status - Western Ontario and McMaster Universities Arthritis Index, primaryOutcomes measure: Patient health status - Global Assessment, secondaryOutcomes measure: Health Ecominics, eligibilityModule sex: ALL, minimumAge: 21 Years, maximumAge: 80 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: University Hospital, status: RECRUITING, city: London, state: Ontario, country: Canada, geoPoint lat: 42.98339, lon: -81.23304, hasResults: False
protocolSection identificationModule nctId: NCT06267456, orgStudyIdInfo id: HÜ- FTR- BD- 01, briefTitle: The Reliability of ULRT in Overhead Athletes and Its Relationship With Selected UEPT, statusModule overallStatus: COMPLETED, startDateStruct date: 2022-01-01, primaryCompletionDateStruct date: 2023-01-01, completionDateStruct date: 2023-01-10, studyFirstPostDateStruct date: 2024-02-20, lastUpdatePostDateStruct date: 2024-02-28, sponsorCollaboratorsModule leadSponsor name: Hacettepe University, class: OTHER, descriptionModule briefSummary: Upper Extremity Rotation Test is a new test the evaluates 90-90 position, which is one of the requirements for overhead throwing. The aim of the study was to evaluate the reliability of the Upper Extremity Rotation Test in overhead athletes and the relationship between the Closed Chain Upper Extremity Stability Test and the Upper Quarter Y Balance Test., conditionsModule conditions: Upper Limb Asymmetry, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NON_RANDOMIZED, interventionModel: SEQUENTIAL, interventionModelDescription: handball, volleyball and basketball players 18-30 years Someone who has been participating in sports for at least three years and trains at least three times a week, primaryPurpose: DIAGNOSTIC, maskingInfo masking: NONE, enrollmentInfo count: 48, type: ACTUAL, armsInterventionsModule interventions name: Upper Limb Rotation Test, interventions name: Closed Kinetic Chain Upper Extremity Stability Test, interventions name: Upper Quarter Y Balance Test, outcomesModule primaryOutcomes measure: The reliability of Upper Extremity Rotation Test, secondaryOutcomes measure: The Relationship Assessment of the Upper Extremity Rotation Test, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 35 Years, stdAges: ADULT, contactsLocationsModule locations facility: Birgül Dıngırdan, city: Kocaeli, state: İzmit, country: Turkey, geoPoint lat: 39.62497, lon: 27.51145, locations facility: Hacettepe University, city: Ankara, country: Turkey, geoPoint lat: 39.91987, lon: 32.85427, hasResults: False
protocolSection identificationModule nctId: NCT06267443, orgStudyIdInfo id: 2023/337, briefTitle: Erector Spina Block or Parasternal Block Plus Chest Tube Wound Infiltration for Cardiac Surgeries, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-03-01, primaryCompletionDateStruct date: 2024-07-01, completionDateStruct date: 2024-08-01, studyFirstPostDateStruct date: 2024-02-20, lastUpdatePostDateStruct date: 2024-02-20, sponsorCollaboratorsModule leadSponsor name: TC Erciyes University, class: OTHER, descriptionModule briefSummary: Pain management is important after coronary artery bypass graft (CABG) surgery. Intravenous morphine is the gold standard for pain relief, but its sedation, cough suppression and decreased bowel movements limit its use. Analgesia with regional methods after surgery provides effective analgesia by reducing morphine consumption. In this study we have planned to compare the erector spina plane block with parasternal block +local infiltration to chest tube areas., conditionsModule conditions: Postoperative Pain, conditions: Postoperative Atelectasis, conditions: Analgesia, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: SINGLE, whoMasked: PARTICIPANT, enrollmentInfo count: 100, type: ESTIMATED, armsInterventionsModule interventions name: Comparison of erector spina plane block, parasternal block plus local infiltration to the tube sides for postoperative analgesia, outcomesModule primaryOutcomes measure: postoperative analgesia, primaryOutcomes measure: postoperative atelectasia, secondaryOutcomes measure: postoperative mechanical ventilation duration, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 80 Years, stdAges: ADULT, stdAges: OLDER_ADULT, hasResults: False